Mebeverine for Pediatric Functional Abdominal Pain: A Randomized, Placebo-Controlled Trial

We evaluated the effectiveness of an antispasmodic, mebeverine, in the treatment of childhood functional abdominal pain (FAP). Children with FAP (n = 115, aged 6–18 years) received mebeverine (135 mg, twice daily) or placebo for 4 weeks. Response was defined as ≥2 point reduction in the 6-point pain...

Descripción completa

Detalles Bibliográficos
Autores principales: Pourmoghaddas, Zahra, Saneian, Hossein, Roohafza, Hamidreza, Gholamrezaei, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095832/
https://www.ncbi.nlm.nih.gov/pubmed/25089264
http://dx.doi.org/10.1155/2014/191026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095832/
https://www.ncbi.nlm.nih.gov/pubmed/25089264
http://dx.doi.org/10.1155/2014/191026

Ejemplares similares